SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-23-000029
Filing Date
2023-04-28
Accepted
2023-04-27 20:38:17
Documents
84
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20230331.htm   iXBRL 10-Q 2167289
2 SECOND AMENDMENT TO COLLABORATION AGREEMENT BETWEEN AMGEN AND BEIGENE exhibit10202-secondamendme.htm EX-10.20 2 74528
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2023331xq1.htm EX-31 19997
4 SECTION 1350 CERTIFICATIONS amgn-ex32_2023331xq1.htm EX-32 9652
  Complete submission text file 0000318154-23-000029.txt   10057496

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20230331.xsd EX-101.SCH 63832
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20230331_cal.xml EX-101.CAL 66522
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20230331_def.xml EX-101.DEF 380802
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20230331_lab.xml EX-101.LAB 706471
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20230331_pre.xml EX-101.PRE 510920
78 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20230331_htm.xml XML 1936793
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 23859578
SIC: 2836 Biological Products, (No Diagnostic Substances)